Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
14.59
-0.70 (-4.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Olema Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 21 | 17.74 | 18.82 | 24.71 | 20.39 | |
| Research & Development | 147.7 | 119.52 | 86.14 | 82.27 | 51.1 | |
| Operating Expenses | 168.7 | 137.26 | 104.96 | 106.99 | 71.49 | |
| Operating Income | -168.7 | -137.26 | -104.96 | -106.99 | -71.49 | |
| Interest & Investment Income | 16.22 | 12.68 | 8.33 | 2.23 | 0.44 | |
| Other Non Operating Income (Expenses) | 0.02 | 0.1 | -0.02 | -0.03 | -0.05 | |
| EBT Excluding Unusual Items | -152.45 | -124.47 | -96.66 | -104.79 | -71.1 | |
| Other Unusual Items | -10 | -5 | - | - | - | |
| Pretax Income | -162.45 | -129.47 | -96.66 | -104.79 | -71.1 | |
| Net Income | -162.45 | -129.47 | -96.66 | -104.79 | -71.1 | |
| Net Income to Common | -162.45 | -129.47 | -96.66 | -104.79 | -71.1 | |
| Shares Outstanding (Basic) | 87 | 59 | 45 | 40 | 40 | |
| Shares Outstanding (Diluted) | 87 | 59 | 45 | 40 | 40 | |
| Shares Change (YoY) | 48.11% | 29.83% | 13.13% | 1.19% | 462.91% | |
| EPS (Basic) | -1.87 | -2.20 | -2.14 | -2.62 | -1.80 | |
| EPS (Diluted) | -1.87 | -2.20 | -2.14 | -2.62 | -1.80 | |
| Free Cash Flow | -146.72 | -104.51 | -83.73 | -82.43 | -52.27 | |
| Free Cash Flow Per Share | -1.69 | -1.78 | -1.85 | -2.06 | -1.32 | |
| EBITDA | -168.21 | -136.87 | -104.58 | -106.63 | -71.33 | |
| D&A For EBITDA | 0.49 | 0.39 | 0.38 | 0.36 | 0.16 | |
| EBIT | -168.7 | -137.26 | -104.96 | -106.99 | -71.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.